The Chemours News

Chemours Upgraded at BMO Capital After Internal Audit Completed

Seeking AlphaApr 9 07:40 ET

Chemours Analyst Ratings

BenzingaApr 9 05:46 ET

Chemours Analyst Ratings

BenzingaApr 2 14:12 ET

Research Alert: CFRA

MT NewswiresApr 1 14:15 ET

Chemours Analyst Ratings

BenzingaMar 5 05:57 ET

Chemours Analyst Ratings

BenzingaFeb 29 12:36 ET

Chemours Company (CC) Receives a Buy From RBC Capital

TipRanksDec 21, 2023 20:47 ET

Chemours Analyst Ratings

BenzingaDec 1, 2023 04:21 ET

JP Morgan Maintains Neutral on Chemours, Lowers Price Target to $26

BenzingaNov 7, 2023 15:09 ET

Chemours Analyst Ratings

BenzingaNov 7, 2023 15:08 ET

Goldman Sachs Maintains Neutral on Chemours, Lowers Price Target to $30

BenzingaOct 31, 2023 09:41 ET

Chemours Analyst Ratings

BenzingaOct 31, 2023 09:40 ET

Barclays Maintains Equal-Weight on Chemours, Lowers Price Target to $28

BenzingaOct 30, 2023 09:26 ET

Chemours Analyst Ratings

BenzingaOct 30, 2023 09:25 ET

RBC Cuts Price Target on Chemours to $28 From $30, Keeps Sector Perform Rating

MT NewswiresOct 30, 2023 07:54 ET

UBS Cuts Chemours Price Target to $37 From $41, Maintains Buy Rating

MT NewswiresOct 27, 2023 11:49 ET

Tronox, Chemicals Peers Decline on J.P. Morgan Downgrade

Seeking AlphaOct 27, 2023 11:20 ET

RBC Cuts Price Target on Chemours to $30 From $40, Keeps Sector Perform Rating

MT NewswiresOct 23, 2023 07:41 ET

BofA Securities Adjusts Price Target on Chemours to $32 From $39, Maintains Neutral Rating

MT NewswiresOct 18, 2023 10:32 ET

UBS Cuts Chemours Price Target to $41 From $47, Maintains Buy Rating

MT NewswiresOct 9, 2023 10:16 ET